Physician profile
Amar Gupta
NPI 1912340159
$25,907.82
in general payments reported to CMS, 2019-2025
6 companies · $19K in 2025
The $19K reported for 2025 was more than what 97% of Plastic Surgery Within The Head and Neck providers received nationally (typical 2025 total: $300).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $39.00 · 2022: $111 · 2023: $61.51 · 2024: $6,600 · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $21K · Travel and Lodging: $3,135 · Food and Beverage: $1,573.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $21,050.00 |
| Travel and Lodging | $3,134.65 |
| Food and Beverage | $1,573.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $24,386.77 | 2023-2025 | |
| Integra Lifesciences Corporation | $1,300.39 | 2024 | Integra, Gentrix, Integra Dermal Regeneration Template |
| Neurent Medical Limited | $70.69 | 2025 | Neuromark Radiofrequency Console, Neuromark System |
| Stryker Corporation | $68.87 | 2022 | |
| Allergan, INC. | $42.10 | 2022 | |
| Glaxosmithkline, LLC. | $39.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amar Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.